BWXT Medical submits Tc-99m generator application to FDA

September 14, 2022, 3:02PMNuclear News

BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration to request approval of its technetium-99m generator for medical imaging. A daughter isotope of molybdenum-99, Tc-99m is used in more than 40 million diagnostic procedures annually. BWXT Medical is a subsidiary of Lynchburg, Va.-based BWX Technologies.

To continue reading, log in or create a free account!

Related Articles

Kairos Power and BWXT team up on TRISO

September 3, 2025, 12:01PMNuclear News

Kairos Power and BWX Technologies announced today that they will work together to “collaboratively explore” optimizing commercial production of TRISO fuel for Kairos’s planned advanced...

Cs-137 contaminated shrimp? What we know

August 21, 2025, 3:00PMNuclear News

Media outlets have been abuzz this week with news of cesium-137 contamination in Great Value (Walmart’s private-label brand) frozen shrimp, according to a Food and Drug Administration...

BWXT advances on TRISO project

July 24, 2025, 7:01AMNuclear News

BWX Technologies (BWXT) has achieved a key milestone in its project to additively manufacture advanced forms of TRISO fuel for Generation IV advanced nuclear reactors. The Lynchburg Technology...